|
Feb 19
|
Predictive Oncology Closes Registered Direct Offering
|
|
Feb 19
|
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
|
Feb 18
|
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
|
|
Feb 10
|
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
|
|
Oct 9
|
Predictive Oncology Inc (POAI) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst ...
|
|
Sep 5
|
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
|
Jul 26
|
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
|
|
Jul 25
|
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
|
|
Jun 11
|
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
|
|
Jan 2
|
Predictive Oncology to Participate in Upcoming San Francisco Conferences
|
|
Nov 8
|
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
|
|
Nov 7
|
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
|
|
Jul 18
|
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
|
|
May 23
|
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
|